Professor Tony Zhang is the Associate Dean (Allied Health) in the School of Health and Biomedical Sciences. His areas of teaching and research are public health, evidence based clinical research, clinical epidemiology, systematic review and research methodologies.
- Associate Dean, Allied Health, School of Health and Biomedical Sciences
- Deputy Director, World Health Organisation (WHO) collaborating centre of traditional medicine
- Co-Deputy Director, China-Australia International Research Centre for Chinese Medicine
- Completion: five PhD, one Master and one BHSci (Hons),
- Current: seven PhD, four Masters and consultant for a number of research projects.
Research funding sources
- Industry funding: approx.: > 1 million.
- PhD research scholarship in the area of Traditional Chinese Medicine at RMIT. A$132,000. 2019-2022. Contract research.
- NHMRC Project Grant (No. 616609). A$560,375. 2010-2015. The effect of a standardised ginseng extract in patients with moderate COPD: a randomised, double-blind trial.
- National Institute of Complementary Medicine Research Grant. A$33,000. 2009-2010. Efficacy and safety of a standardised ginseng extract for patients with moderate COPD.
- Department of Human Services, State Government of Victoria. A$48,000. 2008-2009. Acupuncture for acute pain management at a hospital emergency department.
- Department of Innovation, Industry and Regional Services, State Government of Victoria. A$208,000. 2006–2008. Herbal medicine used by Victorians.
Competitive teaching grants
- New Colombo Plan (for Clinical placement), Department of Foreign Affairs and Trade, Australian Government, A$660,000. 2018-2022.
- New Colombo Plan (for Clinical placement), Department of Foreign Affairs and Trade, Australian Government, A$154,000. 2017.
- Short Term Mobility Program (for Clinical placement), Department of Education, Australian Government, A$11,500. 2014.
- Inaugural AsiaBound Grant, Department of Industry, Innovation, Climate Change, Science, Research and Tertiary Education, Australian Government, A$21,500. 2013.
- Citations for Outstanding Contributions to Student Learning (Program Award) “For holistic, innovative, problem-based teaching that enables students to blend Western medical science with traditional knowledge so as to become competent, evidence-based Chinese medicine practitioners”. Office for Learning & Teaching, Department of Industry, Innovation, Science, Research and Tertiary Education, Australian Government, Sept 2013.
- RMIT Teaching Award in Innovation in Curricula, Learning and Teaching (Program Award), Nov 2012.
- Research Excellence Award, National Institute of Complementary Medicine, Australia, Jun 2009
- Evidence-based public health research; Epidemiological studies; Randomised controlled trial; Systematic review and meta-analysis; Clinical epidemiology; Biostatistics and Research methods.
- PhD, RMIT University, Melbourne, Australia
- Master of Public Health (MPH), University of New South Wales, Sydney, Australia
- Bachelor of Medicine (BMed), Guangxi University of Chinese Medicine, P.R. China
- Member, Natural Therapies Working Committee (NTWC), National Health & Medical Research Council, Australian Government
- Invited Expert, Chinese Medicine Board of Australia Regulatory Examinations Development Group
- Consultant, World Health Organisation Western Pacific Regional Office (WHO-WPRO), WHO
- Expert Advisor (Assessor), Tertiary Education Quality and Standards Agency (TEQSA)
- External Reviewer, National Health & Medical Research Council (NHMRC)
- External Assessor, Australian Research Council (ARC)
- External Assessor, Office for Learning and Teaching Grants, Australian Government
- External Reviewer, Health Research Council, New Zealand Government
- Grant Review Referee Panel (2014-present, reviewed >30 grant applications), Health and Medical Research Fund, Hong Kong Government
- HDR Thesis Examiner: Sydney University, University of New South Wales, Deakin University, La Trobe University, University Technology of Sydney, Charles Sturt University, Griffith University, University of Western Sydney, Central Queensland University
- Panel Member, Accreditation of Master of Science Program, Hong Kong Baptist University
- Vetting Panel, BSci (Hons) Chinese Med, International Medical University, Malaysia
Editorial Board Member (n=7)
- American Journal of Chinese Medicine (IF=2.959, Q1)
- BMC Complementary Medicine and Therapies (IF=2.610, Q1)
- Discovery Phytomedicine (ISSN 3698-7859)
- Journal of Acupuncture and Herbs (ISSN 2001-7464)
- Journal of Traditional Chinese Medicine (ISSN 0254-6272)
- Journal of Acupuncture Research (ISSN 2586-288X)
- Longhua Chinese Medicine (ISSN 2616-2806)
Reviewer for peer-reviewed journals
- American Journal of Public Health (IF=3.926)
- American Journal of Chinese Medicine (Am J CM) (IF=1.979)
- BMC Complementary and Alternative Medicine (IF=2.241)
- British Journal of Cancer (IF=5.042)
- Chinese Medicine (BMC)
- Cochrane Database Systematic Review (IF=5.715)
- Complementary Therapies in Medicine (IF=1.872)
- Evidence-based Complementary and Alternative Medicine (IF=4.774)
- Health and Quality of Life Outcomes (IF=2.112)
- Health Sociology Review (IF=0.493)
- ISRN Family Medicine
- Medical Care (An official journal of the American Public Health Association) (IF=3.411)
- Pharmacoepidemiology & Drug Safety (IF=2.528)
- Plant Foods for Human Nutrition (IF=2.505)
- Statistics in Medicine (IF=1.877)
- The Journal of Alternative and Complementary Medicine (JACM) (IF=1.585)
- The Australian Journal of Acupuncture and Chinese Medicine (AJACM)
- The Journal of Complementary & Integrative Medicine (JCIM)
- The Journal of Chinese Medicine Research and Development (JCMRD)
Contribution to scientific conferences
- Invited Speaker and Session Chair, International acupuncture conference (ISAMS 2012), Sydney, Oct 2012. (100% funded by organiser).
- Invited Speaker and Session Chair, The 3rd Global University Network of Transitional Medicine, TaiChung, Taiwan, Dec 2011. (100% funded by organiser).
- Organising committee (academic panel) member of the 6th World Congress on Chinese Medicine, Melbourne (2009)
- Panel Chair for the session on Clinical Research of Integrative Medicine at The 3rd World Integrative Medicine Congress, China (2007)
- Invited keynote speaker in the China-Australia Chinese Medicine Forum, Melbourne (2008)
- Invited Speaker, The 3rd Global University Network of Transitional Medicine, Taiwan, Dec 2011
- Speaker at international conferences: The 5th International Congress on Complementary Medicine Research (2010The 5th Symposium on Acupuncture and Meridian Studies (2009 The 3rd World Integrative Medicine Congress (2007 International Epidemiological Association Western Pacific Region Scientific Meeting (2007 The 3rd International Conference on Healthy Ageing and Longevity (2006The 1st World Congress in Chinese Medicine (2003).
- Member of the Sciences, Engineering and Technology (SET) College Board (2005–06), Acting HDR Coordinator for the School of Health Sciences (2007–08), Member of the SET College Higher Degree Research Committee (2007–08), Board Member (and Company Secretary) of the Australian Research Centre for Complementary and Alternative Medicines (ARCCAM) Ltd (2009-2010), Secretary of Chinese Medicine Confucius Institute at RMIT University (2010).
- He, Y.,Zhang, H.,Li, Y.,Long, S.,Xiao, S.,May, B.,Zhang, A.,Guo, X.,Xue, C.,Lu, C. (2022). Acupuncture combined with opioids for cancer pain: a pilot pragmatic randomized controlled trial In: Acupuncture in Medicine, 40, 133 - 141
- Ge, L.,Wang, Q.,He, Y.,Zhang, T.,Xue, C. C., et al, . (2022). Acupuncture for cancer pain: an evidence-based clinical practice guideline In: Chinese Medicine, 17, 1 - 12
- Lyu, S.,Zhang, C.,Zhang, T.,Sun, J.,Xue, C.,Guo, X. (2022). Migraine patients visiting Chinese medicine hospital: Protocol for a prospective, registry-based, real-world observational cohort study In: PLoS One, 17, 1 - 12
- Coyle, M.,Zhang, A.,Xue, C. (2022). Evidence-based Clinical Chinese Medicine: Volume 28: Endometriosis, World Scientific Publishing Company, Singapore
- Brosnan, C.,Collyer, F.,Willis, K.,Zhang, A. (2022). Chinese Medicine as Boundary Object(s): Examining TCM’s Integration into International Science through the Case of Australian-Chinese Research Collaboration. In: East Asian Science, Technology and Society, , 1 - 24
- Zhang, S.,Zhang, D.,Zhang, M.,Zhang, A.,Xue, C.,Lu, C.,Lin, D.,Li, Y.,Guo, X. (2021). Evidence-Based Clinical Chinese Medicine - Volume 29: Cervical Radiculopathy, World Scientific, Singapore
- Chen, M.,Gu, Y.,Zhang, A.,Sze, D.,Mo, S.,May, B. (2021). Biological effects and mechanisms of matrine and other constituents of Sophora flavescens in colorectal cancer In: Pharmacological Research, 171, 1 - 14
- Ling, J.,Olga, M.,Khunti, K.,Zhang, A.,Xue, C. (2021). Therapeutic inertia in the management of dyslipidaemia and hypertension in incident type 2 diabetes and the resulting risk factor burden: Real-world evidence from primary care In: Diabetes, Obesity and Metabolism, 23, 1518 - 1531
- Coyle, M.,Liu, J.,Yang, H.,Wang, K.,Zhang, A.,Guo, X.,Lu, C.,Xue, C. (2021). Licorice (Glycyrrhiza spp.) and jujube (Ziziphus jujuba Mill.) formula for menopausal symptoms: Classical records, clinical evidence and experimental data In: Complementary Therapies in Clinical Practice, 44, 1 - 7
- May, B.,Lin, W.,Zhang, T.,Xue, C.,Luo, Q.,Guo, X.,Li, Y.,Lu, C. (2021). Evidence-Based Clinical Chinese Medicine - Volume 25: Rhinosinusitis, World Scientific , Singapore
19 PhD Completions and 1 Masters by Research Completions9 PhD Current Supervisions
- Culture aspects in the Development of evidence-based Chinese Medicine - Stage 9. Funded by: Confucius Institute Headquarters Business Development Program Grant 2017 from (2019 to 2020)
- Culture aspects in the Development of evidence-based Chinese Medicine - Stage 7. Funded by: Confucius Institute Headquarters Business Development Program Grant 2017 from (2017 to 2019)
- Culture aspects in the Development of evidence-based Chinese Medicine - Stage 6. Funded by: Confucius Institute Headquarters Business Development Program Grant 2016 from (2016 to 2018)
- Cultural Aspects in the Development of Evidence-Based Chinese Medicine - Stage 5. Funded by: Confucius Institute Headquarters Business Development Program Grant pre-2014 from (2015 to 2018)
- Cultural Aspects in the Development of Evidence-Based Chinese Medicine - Stage 4. Funded by: Confucius Institute Headquarters Business Development Program Grant pre-2014 from (2014 to 2014)